Webinar Series 1

Crystal Pharmatech is pleased to announce a webinar series on “Selecting the Right API Form and Formulation”. Choosing the right form and formulation is a continuously evolving field. To stay at the cutting edge of this field internally and continuously educate the community externally, Crystal Pharmatech has gathered a panel of distinguished scientists from various disciplines to support our “Crystal Clear Pathways to Select API Form and Formulation”. The panel serves to educate pharmaceutical companies on the importance of proper selection of API phase and formulation. This panel has combined to assess form and formulation for hundreds of development compounds. Experiencing it all, they've seen the successes and the horror stories of development and are now willing to share them with you through case studies, panel discussions, and webinars.

Webinar Series 2

Crystal Pharmatech is pleased to announce our new webinar series: "Molecules-to-Medicine: Accelerating Drug Development through Collaboration". Purpose: To communicate the extraordinary ingenuity taking place in 21st century drug discovery and development and that a good idea is just the first step in creating a medicine. In a nutshell, why CMC matters and how collaboration can accelerate development. Presenters: Innovative pharmaceutical scientists and entrepreneurs showcasing novel therapeutic technologies with a focus on how a molecule becomes a medicine.

Webinar Series 3

Creating a medicine does not stop with just a good idea; it is only the first setp. To take you through the journey of modern drug discovery and development, Crystal Pharmatech is gearing up for another must-watch webinar series. The "Advanced Characterization: Tools for Accelerating Molecules to Medicine" aims to communicate the extraordinary ingenuity taking place in the 21st-century drug development field and promote collaboration. It is expected to gather like-minded innovative individuals toshare fresh ideas and discuss the latest tools and technology to fast-track the creation of drugs.